307 related articles for article (PubMed ID: 16902598)
1. Montelukast prevents the decrease of interleukin-10 and inhibits NF-kappaB activation in inflammatory airway of asthmatic guinea pigs.
Wu Y; Zhou C; Tao J; Li S
Can J Physiol Pharmacol; 2006 May; 84(5):531-7. PubMed ID: 16902598
[TBL] [Abstract][Full Text] [Related]
2. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
[TBL] [Abstract][Full Text] [Related]
3. Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules.
Maeba S; Ichiyama T; Ueno Y; Makata H; Matsubara T; Furukawa S
Ann Allergy Asthma Immunol; 2005 Jun; 94(6):670-4. PubMed ID: 15984600
[TBL] [Abstract][Full Text] [Related]
4. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model.
Muraki M; Imbe S; Santo H; Sato R; Sano H; Iwanaga T; Tohda Y
Int Arch Allergy Immunol; 2011; 155 Suppl 1():90-5. PubMed ID: 21646802
[TBL] [Abstract][Full Text] [Related]
5. Montelukast modulates lung CysLT(1) receptor expression and eosinophilic inflammation in asthmatic mice.
Zhang YJ; Zhang L; Wang SB; Shen HH; Wei EQ
Acta Pharmacol Sin; 2004 Oct; 25(10):1341-6. PubMed ID: 15456537
[TBL] [Abstract][Full Text] [Related]
6. Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.
Ramsay CF; Sullivan P; Gizycki M; Wang D; Swern AS; Barnes NC; Reiss TF; Jeffery PK
Respir Med; 2009 Jul; 103(7):995-1003. PubMed ID: 19249198
[TBL] [Abstract][Full Text] [Related]
7. Administration of antisense phosphorothioate oligonucleotide to the p65 subunit of NF-kappaB inhibits established asthmatic reaction in mice.
Choi IW; Kim DK; Ko HM; Lee HK
Int Immunopharmacol; 2004 Dec; 4(14):1817-28. PubMed ID: 15531297
[TBL] [Abstract][Full Text] [Related]
8. Effects of (±)-praeruptorin A on airway inflammation, airway hyperresponsiveness and NF-κB signaling pathway in a mouse model of allergic airway disease.
Xiong Y; Wang J; Wu F; Li J; Zhou L; Kong L
Eur J Pharmacol; 2012 May; 683(1-3):316-24. PubMed ID: 22449378
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic effects of nobiletin, a polymethoxyflavonoid, on eosinophilic airway inflammation of asthmatic rats and relevant mechanisms.
Wu YQ; Zhou CH; Tao J; Li SN
Life Sci; 2006 May; 78(23):2689-96. PubMed ID: 16337971
[TBL] [Abstract][Full Text] [Related]
10. [Effects of montelukast on apoptosis and Fas mRNA expression of eosinophils in airway of asthmatic guinea pigs].
Wu YQ; Zhou CH; Zhang HQ
Yao Xue Xue Bao; 2004 Oct; 39(10):769-73. PubMed ID: 15700813
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model.
Kim DY; Ryu SY; Lim JE; Lee YS; Ro JY
Eur J Pharmacol; 2007 Feb; 557(1):76-86. PubMed ID: 17169357
[TBL] [Abstract][Full Text] [Related]
12. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
13. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
[TBL] [Abstract][Full Text] [Related]
14. Effects of glucocorticoid and cysteinyl leukotriene 1 receptor antagonist on CD(34+) hematopoietic cells in bone marrow of asthmatic mice.
Mao H; Yin KS; Wang ZL; Li FY; Zhang XL; Liu CT; Lei S
Chin Med J (Engl); 2004 Apr; 117(4):592-7. PubMed ID: 15109455
[TBL] [Abstract][Full Text] [Related]
15. [The effects of anti-inflammatory and anti-asthmatic agents on CD34+ hematopoietic cells in bone marrow of asthmatic mice].
Mao H; Wang ZL; Liu CT; Yin KS; Yu YH; Deng YL
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):229-33. PubMed ID: 15144611
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of anti-IL-1β IgY in guinea pigs with allergic asthma induced by ovalbumin.
Wei-xu H; Qin X; Zhu W; Yuan-yi C; Li-feng Z; Zhi-yong L; Dan H; Xiao-mu W; Guo-zhu H
Mol Immunol; 2014 Mar; 58(1):139-49. PubMed ID: 24355520
[TBL] [Abstract][Full Text] [Related]
17. Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity.
Tahan F; Jazrawi E; Moodley T; Rovati GE; Adcock IM
Clin Exp Allergy; 2008 May; 38(5):805-11. PubMed ID: 18325031
[TBL] [Abstract][Full Text] [Related]
18. Suppression of ovalbumin-induced Th2-driven airway inflammation by β-sitosterol in a guinea pig model of asthma.
Mahajan SG; Mehta AA
Eur J Pharmacol; 2011 Jan; 650(1):458-64. PubMed ID: 20946894
[TBL] [Abstract][Full Text] [Related]
19. [An experimental study on the regulation of the expression of Th2 cytokines by nuclear factor-kappaB and protein kinase C in asthma].
Xiong W; Xu Y; Zhang Z
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):355-9. PubMed ID: 11802989
[TBL] [Abstract][Full Text] [Related]
20. Narirutin inhibits airway inflammation in an allergic mouse model.
Funaguchi N; Ohno Y; La BL; Asai T; Yuhgetsu H; Sawada M; Takemura G; Minatoguchi S; Fujiwara T; Fujiwara H
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):766-70. PubMed ID: 17600554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
